http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-887721-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7780e9d205ef3d354fe484bbc65b155c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J75-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00
filingDate 1958-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1962-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-887721-A
titleOfInvention Cyclopentanophenanthrene derivatives
abstract The invention comprises 19-androstenes of the formula <FORM:0887721/IV (b)/1> wherein R is an alkyl, alkenyl or alkinyl group containing not more than six carbon atoms, R1 and R2 each represent hydrogen or a hydrocarbon carboxylic acyl group of from 2-12 carbons atoms, and their preparation from the corresponding 17a -alkyl or alkinyl derivative of 19-nor-D 4-androsten-17b -ol-3-one by enol esterification, selective hydrolysis of the enol ester group and reduction of the D 3 bond with an alkali metal double hydride, preferably with sodium borohydride and optionally saponifying 17-ester group, hydrogenating a 17-alkinyl group to the corresponding 17-alkenyl or alkyl group and acylating either or both the 3- and 17-hydroxy groups. The enol esterification is effected with isopropenyl acetate or with an acid anhydride and an acid catalyst, and specified acyl groups are acetyl, propinyl, butyroyl, hemisuccinyl, caproyl, benzoyl, trimethylacetyl, phenoxyacetyl, phenoxypropionyl, phenylpropionyl, cyclopentylpropionyl, dichlorophenoxyacetyl, and b -chloropropionyl. The saponification process is preferably conducted with lithium aluminium hydride. In examples: (1) 17a -methyl-19-nor-testosterone is refluxed with acetic anhydride and pyridine, the resulting acetate heated with isopropenyl acetate and H2SO4 and the diacetate of 17a -methyl-19-nor-D 3,5-androstadiene 3b ,17b -diol reduced with NaBH4 and saponified with ethereal LiAlH4 to 17a -methyl-19-nor-D 5-androstene-3b ,17b -diol, characterised (2) to (4) as its 3-acetate, 3,17-diacetate, and 3-propionate-17-acetate; (5) 17a -ethinyl-19-nortestosterone treated as in (1) gives 17a -ethinyl-19-nor-D 5 androstene-3b ,17b -diol which (6) is hydrogenated over Pd on CaCO3 to the 17a -vinyl compound and then over Pd on charcoal to 17a - ethyl - 19 - nor - D 5 - androstene - 3b , 17b - diol; (8) and (9) the 17-acetate of the 17a -ethinyl compound is similarly reduced in two stages; (10) 17a -ethinyl-19-nor-testosterone is heated with acetic anhydride and p-toluene sulphonic acid giving the diacetate of 17a -ethinyl-19-nor-D 3,5-androstadiene-3,17b -diol; (11) and (12), the dipropionate is likewise obtained and converted to the 17-propionate of 17a -ethinyl-19-nor-D 5-androstene-3b ,17b -diol, and its 17-vinyl and 17-ethyl analogues; (13) to (15) and (19) illustrate similar reactions with 17a -propionyl-, and 17a -butinyl compounds; (16) to (18) 17a -ethinyl-19-nor-D 5 androstene-3b ,17b -diol is characterised as its 3-acetate, 3,17-diacetate, and 3-propionate-17-acetate.
priorityDate 1957-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10634
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18645702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22959485
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451404211
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452932707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453467280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18355900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446554
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20285045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4311764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454306093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421810488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166653
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420291066
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449445756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155

Total number of triples: 48.